Assertio Holdings, Inc.

ASRT

Explore Our Financial Data > Companies > Assertio Holdings, Inc.

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	ASRT
CIK	0001808665
SIC	2834
Sector	Manufacturing
Industry Category	Pharmaceutical Products
Industry Group	Pharmaceutical Preparations

Contact

Address	100 S. SAUNDERS ROAD, SUITE 300, LAKE FOREST, IL, 60045
Website	assertiotx.com
Phone	(224) 419-7106
CEO	Daniel A. Peisert
Employees	20

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$119.00 million
Pre-Tax Income	$-30.45 million
Net Income	$-30.61 million
Net Income to Common	$-30.61 million
EPS	$-0.32

View All

Balance Sheet

Cash	$35.00 million
Assets	$286.43 million
Liabilities	$177.90 million
Common Equity	$108.53 million
Liabilities & Equity	$286.43 million

View All

Cash Flow Statement

Net Income	$-30.61 million
Cash From Operating Activities	$6.36 million
Cash From Investing Activities	$-51.85 million
Cash From Financing Activities	$-255,000.00
Change in Cash	$-45.74 million

View All

Calculations

NOPAT	$-23.36 million
EBITDA	$-781,000.00
Price to Earnings	N/A
Price to Book	$0.58
ROE	-25.19%

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

New Strong Sell Stocks for June 30th

AEG, APOG and ASRT have been added to the Zacks Rank #5 (Strong Sell) List on June 30, 2025.

Article Link

New Strong Sell Stocks for June 25th

ASRT, BLIN and AMKR have been added to the Zacks Rank #5 (Strong Sell) List on June 25 2025.

Article Link

ASRT Launches Phase Two of the Be Seen Campaign

ALBUQUERQUE, NEW MEXICO / ACCESS Newswire / June 23, 2025 / The American Society of Radiologic Technologists has launched the second phase of itsBe Seen public awareness campaign . ASRT Be Seen Campaign Phase Two Radiologic technologist in a clinical ...

Article Link

New Strong Sell Stocks for June 18th

APLE, ASRT and BOOT have been added to the Zacks Rank #5 (Strong Sell) List on June 18, 2025.

Article Link

Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025

LAKE FOREST, Ill., May 19, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the virtual Alliance Global Partners Healthcare Company Showcase, taking place Wednesday, May 21, 2025. Mr. O’Grady’s fireside chat will be webcast live at 11:20 a.m. ET. To join the event, please register at https://us02web.zoom.us/webinar/register/WN_jB1HgKLvQFmUfC6VBT11mw#/registration, or visit

Article Link